Pro-Dex (NASDAQ:PDEX) CEO Kirk Richard Lee Van, Jr. Sells 5,872 Shares of Stock

Pro-Dex, Inc. (NASDAQ:PDEX) CEO Kirk Richard Lee Van, Jr. sold 5,872 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $62.81, for a total value of $368,820.32. Following the completion of the transaction, the chief executive officer directly owned 93,835 shares in the company, valued at approximately $5,893,776.35. This represents a 5.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Pro-Dex Price Performance

Pro-Dex stock opened at $65.15 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.14 and a current ratio of 3.67. The firm has a market cap of $207.83 million, a P/E ratio of 18.00 and a beta of -0.12. The business’s fifty day moving average is $53.42 and its two-hundred day moving average is $44.58. Pro-Dex, Inc. has a 52 week low of $23.47 and a 52 week high of $65.88.

Pro-Dex (NASDAQ:PDEX) last posted its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.58. The company had revenue of $19.95 million for the quarter, compared to analyst estimates of $17.90 million. Pro-Dex had a return on equity of 22.78% and a net margin of 16.08%. Equities research analysts forecast that Pro-Dex, Inc. will post 3.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have commented on PDEX. Zacks Research raised Pro-Dex to a “hold” rating in a research note on Tuesday, May 19th. Ascendiant Capital Markets boosted their price objective on Pro-Dex from $56.00 to $70.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Pro-Dex in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Pro-Dex currently has a consensus rating of “Hold” and an average price target of $70.00.

Institutional Investors Weigh In On Pro-Dex

A number of institutional investors and hedge funds have recently made changes to their positions in PDEX. Geode Capital Management LLC raised its position in shares of Pro-Dex by 93.2% during the second quarter. Geode Capital Management LLC now owns 51,668 shares of the medical instruments supplier’s stock worth $2,255,000 after acquiring an additional 24,927 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Pro-Dex by 67.7% during the second quarter. JPMorgan Chase & Co. now owns 35,877 shares of the medical instruments supplier’s stock worth $1,566,000 after acquiring an additional 14,479 shares during the last quarter. Punch & Associates Investment Management Inc. raised its position in shares of Pro-Dex by 42.1% during the third quarter. Punch & Associates Investment Management Inc. now owns 48,608 shares of the medical instruments supplier’s stock worth $1,645,000 after acquiring an additional 14,408 shares during the last quarter. Corsair Capital Management L.P. bought a new stake in shares of Pro-Dex during the first quarter worth $532,000. Finally, Jane Street Group LLC bought a new stake in shares of Pro-Dex during the first quarter worth $321,000. Institutional investors own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.